PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
05-Mar-2024 Lundbeck presents encouraging results from the Lu AF82422 trial for Multiple System Atrophy at the international AD/PD 2024 conference on neurodegenerative disorders Lundbeck A/S
05-Mar-2024 ViiV Healthcare presents phase I clinical trial findings of a cabotegravir long-acting injectable investigational formulation allowing at least four months between doses ViiV Healthcare
05-Mar-2024 CluePoints’ Audit Trail Review Project Wins Award for Innovation in the Management of Clinical Data Award CluePoints
29-Feb-2024 Sequani invests in industry leading facilities as it eyes future growth Sequani
29-Feb-2024 Medidata and Thermo Fisher Scientific’s PPD Clinical Research Business Collaborate to Accelerate Clinical Trials Innovation Medidata
28-Feb-2024 Avance Clinical CEO Talks with SCRIP about US Biotech Sector "Green Shoots" and a New CRO Report Avance Clinical
27-Feb-2024 PureTech Founded Entity Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx® for Pediatric ADHD Patients in Japan PureTech Health plc
27-Feb-2024 Curve Therapeutics raises £40.5 million to turbocharge discovery platform and advance breakthrough pipeline Curve Therapeutics
27-Feb-2024 CellProthera collaborates with Japanese stem cell experts at Shonan-Kamakura General Hospital (SKGH) on clinical manufacturing for upcoming autologous stem cell trials in ischemic diseases CellProthera
27-Feb-2024 Dr. Pfleger Arzneimittel Scales Digital Field Engagement with Veeva Commercial Cloud Veeva
27-Feb-2024 PureTech to Present at Two Upcoming Investor Conferences PureTech Health
27-Feb-2024 Key Insights from the DACH Healthcare Innovation Summit: More Collaboration, Interoperability, and Technology to Enhance Healthcare Systems Response Bamberg Health
26-Feb-2024 BeiGene Receives Positive CHMP Opinion for Tislelizumab as Treatment for Non-Small Cell Lung Cancer BeiGene
26-Feb-2024 MANDARA Phase III data published in New England Journal of Medicine show remission is an achievable goal in eosinophilic granulomatosis with polyangiitis (EGPA) with Fasenra AstraZeneca
26-Feb-2024 International working group in pharmacovigilance launches new studies into causal inference and data sources Drug Safety Research Unit
23-Feb-2024 How to make sure patients get faster and fairer access to new medicines Association of the British Pharmaceutical Industry (ABPI)
23-Feb-2024 Rare Disease Day: Emmes Endpoints Solutions Submits Duchenne Video Assessment Qualification Plan to FDA Emmes
22-Feb-2024 UK life science industry sets out priorities for the Budget British Pharmaceutical Industry (ABPI)
22-Feb-2024 New Pistoia Alliance Survey Reveals Only 9% Of Life Science Professionals Understand Laws Regulating AI in US and EU The Pistoia Alliance
22-Feb-2024 EVERSANA CONSULTING Named a Top Consulting Firm in Asia Pacific Region for the Second Consecutive Year EVERSANA